Results 1 to 10 of about 41,522 (262)

Inhaled Corticosteroids [PDF]

open access: yesPharmaceuticals, 2010
Inhaled corticosteroids (ICS) are the most effective controllers of asthma. They suppress inflammation mainly by switching off multiple activated inflammatory genes through reversing histone acetylation via the recruitment of histone deacetylase 2 (HDAC2)
Peter J. Barnes
doaj   +4 more sources

Minimising inhaled corticosteroids for COPD [PDF]

open access: yesAfrican Journal of Primary Health Care & Family Medicine
This Therapeutic Letter considers the evidence for inhaled corticosteroids (ICS) as a treatment for Chronic Obstructive Pulmonary Disease (COPD). Drug therapy aims to alleviate symptoms, enhance functional capacity and prevent exacerbations, but has not ...
Benji Heran   +2 more
doaj   +2 more sources

Bilateral Patellar Tendon Rupture in a 64-Year-Old Man: Possible Interaction of Inhaled Corticosteroids, Age and Mechanical Stress [PDF]

open access: yesCase Reports in Orthopedics
Bilateral rupture of the patellar tendon is a rare occurrence, most often associated with systemic disease or exposure to systemic corticosteroids or fluoroquinolones.
Mohamed Jalaleddin   +4 more
doaj   +2 more sources

Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis.

open access: yesPLoS ONE, 2023
Inhaled corticosteroids are known to be relatively safe for long-term use in inflammatory respiratory diseases and it has been repurposed as one of the potential therapies for outpatients with coronavirus disease 2019 (COVID-19).
Su-Yeon Yu   +6 more
doaj   +1 more source

Inhaled corticosteroids for bronchiectasis [PDF]

open access: yesCochrane Database of Systematic Reviews, 2018
Bronchiectasis is being increasingly diagnosed and recognised as an important contributor to chronic lung disease in both adults and children in high- and low-income countries. It is characterised by irreversible dilatation of airways and is generally associated with airway inflammation and chronic bacterial infection.
Kapur, Nitin   +4 more
openaire   +3 more sources

Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study [PDF]

open access: yesActa Medica Academica, 2015
Objective. Inhaled corticosteroids and inhaled beta agonists were shown to decrease the lung injury in animal models. We investigated the association of pre-hospital use of inhaled corticosteroids and inhaled beta agonists with the incidence of Acute ...
Asif Muhammad Mangi   +5 more
doaj   +1 more source

Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients

open access: yesAllergy, Asthma & Clinical Immunology, 2022
Objectives Oral corticosteroids reduce the antibody titer of the BNT162b2 mRNA vaccine against SARS-CoV-2. To date, the effect of inhaled corticosteroids on antibody titers is unknown. Study design The design of this study is retrospective study. Methods
Takeo Nakajima   +9 more
doaj   +1 more source

Inhaled Corticosteroids [PDF]

open access: yesJournal of Allergy and Clinical Immunology, 2003
The Journal of Allergy and Clinical Immunology 112 (2003) S1-S40.
'Division of Endocrinology, University of Wisconsin Children''s Hospital, Madison, Wis, USA' ( host institution )   +6 more
openaire   +2 more sources

HbA1c Levels in Children with Persistent Asthma on Inhaled Corticoids: A Descriptive Cohort Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: Asthma is one of the most common chronic respiratory conditions in children. Inhaled corticoids have revolutionised the treatment of asthma but long-term inhaled and systemic corticoids have been shown to have an effect on glucose ...
Kaarthikeyani Sankaravadivelu   +2 more
doaj   +1 more source

Inhaled corticosteroids in COPD: a case in favour [PDF]

open access: yesEuropean Respiratory Journal, 2009
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, which is characterised by reduced post-bronchodilator lung function in all patients 1. Although hyperresponsiveness and acute bronchodilator reversibility have been regarded as characteristics of asthma, it is now generally acknowledged that these clinical features are also ...
Postma, D. S., Calverley, P.
openaire   +2 more sources

Home - About - Disclaimer - Privacy